2-allylchromans

ABSTRACT

Novel 2-halochromans and their coupling to various nucleophiles to produce Vitamin E and as well as novel intermediates for Vitamin E.

This is a division of application Ser. No. 06/932,970 filed Nov. 20,1986, now U.S. Pat. No. 4,752,646, which is a continuation-in-part ofSer. No. 06/821,590 filed Jan. 23, 1986 now abandoned.

SUMMARY OF THE INVENTION

In accordance with this invention, compounds of the formula: ##STR1##wherein X is halogen; and R¹ is methyl or a hydroxy protecting groupremovable by basic hydrolysis or hydrogenolysis; are prepared fromcompounds of the formula: ##STR2## wherein R¹ is as above, and R⁴ ishydrogen or lower alkyl.

The compounds of formula I are intermediates in the formation of VitaminE or other known intermediates thereof. The compounds of formula I canbe converted to Vitamin E or intermediates thereof by reaction with acompound of the formula:

    R.sup.2 Y                                                  III

wherein Y is an alkali metal or MgX; R² is ##STR3## R³ is loweralkyl;and X is halogen

In the reaction of the compound of formula I with the compound offormula III, depending upon R², the following compounds are formed##STR4## wherein R¹ is as above; and R³ is lower alkyl.

In accordance with this invention the compounds of formula IV and V areintermediates for Vitamin E, wherein the compound of formula VI is theimmediate known precursor for Vitamin E.

DETAILED DESCRIPTION

As used throughout this application, the term halogen includes all fourhalogens i.e., fluorine, chlorine, bromine and iodine with chlorine,bromine and iodine being preferred and chlorine being especiallypreferred. Furthermore, as used throughout the application, the term"lower alkyl" includes both straight and branched chain alkyl groupshaving from 1 to 7 carbon atoms such as methyl, ethyl, propyl, n-butyl,isopropyl etc. with methyl and ethyl being preferred. Also as usedherein, the term "lower alkanoic acids" comprehend an alkanoic acid offrom 1 to 7 carbon atoms such as acetic acid, formic acid and propionicacid.

As also used herein, the term "aryl" signifies mononuclear aromatichydrocarbon groups such as phenyl, which can be unsubstituted orsubstituted in one or more position with a lower alkylenedioxy, ahalogen, nitro, lower alkyl or lower alkoxy substituent and polynucleararyl groups such as naphthyl, which can be unsubstituted or substitutedwith one or more of the aforementioned groups. The preferred aryl groupis the substituted or unsubstituted mononuclear aryl group, phenyl. Theterm "aryl lower alkyl" comprehends aryl lower alkyl groups wherein aryland lower alkyl are as defined above, preferably those groups wherelower alkyl is methyl. The preferred aryl lower alkyl substituent isbenzyl. The term "aryl lower alkanoic acid" comprehends aryl loweralkanoic acid groups where "aryl" and "lower alkanoic acid" are asdefined above and includes aryl carboxylic acids. The preferred "aryllower alkanoic acid" being an arylcarboxylic acid such as benzoic acid.

As used herein, lower alkoxy comprehends lower alkoxy groups having 1 to7 carbon atoms such as methoxy and ethoxy. The term "loweralkylenedioxy" designates lower alkylenedioxy group contain from 2 to 7carbon atoms such as ethylenedioxy.

In the compound of formula II which is used as starting material forVitamin E or intermediates for Vitamin E, R¹ can be any protecting groupremovable by basic hydrolysis or by hydrogenolysis. Therefore theconventional protecting groups removable either by basic hydrolysis orhydrogenolysis to yield the hydroxy group can be utilized as theprotecting group R¹ in the process of this invention. Among theseprotecting groups are included ester groups derived from a loweralkanoic or aryl lower alkanoic acid. Any conventional method of formingthese ester protecting groups can be utilized in the process of thisinvention. Any conventional ether protecting groups removable byhydrogenolysis can be utilized in this invention. Among the preferredether protecting groups are the aryl methyl ethers such as benzylethers. These protecting groups can be removed by hydrogenolysis toyield the corresponding hydroxy group by conventional means well knownin the art.

The compound of formula II is converted to the compound of formula I bytreating the compound of formula II with a hydrohalic acid preferablyhydrochloric acid at temperatures of from -30° C. to +30° C. preferablyfrom -10° C. to +10° C. in a inert organic solvent medium. Generally,this reaction is carried out under anhydrous conditions. In carrying outthis reaction, it is generally preferred to utilize an inert organicsolvent. Any conventional ether solvent can be utilized to carry outthis reaction. Among the preferred ether solvents are diethylether,tetrahydrofuran, glyme and diglyme.

In the next step of this invention, the compound of formula I is reactedwith the compound of formula III to produce either the compound offormula IV or the compound of formula V or the compound of formula VI.Formation of either the compound of formula IV, V or VI will depend uponthe precise substituent utilized for R₂ in the compound of formula III.

Where Y in the compound of formula III is an alkali metal, Y can be anyconventional alkali metal, such as lithium, sodium or potassium withsodium and potassium being especially preferred. The reaction of thecompound of formula I with the compound of formula III where Y is alkalimetal is carried out under anhydrous conditions in an inert organicsolvent medium. In carrying out this reaction any conventional inertorganic solvent can be utilized as the reaction medium with ethersolvents such as those mentioned hereinbefore being particularlysuitable. The preferred inert organic solvent medium is diethylether. Incarrying out this reaction temperature are from -30° C. to +30° C. canbe utilized with temperatures of from 0° C. to 15° C. being especiallypreferred.

When Y in the compound of formula III is MgX, the compound of formula Iand the compound of formula III are reacted to produce either thecompound of formula IV, V or VI, depending upon R², in an inert organicsolvent at temperatures ranging from -100° C. to 0° C. It is preferredto carry out this reaction at temperatures from -80° to -30° C. Thisreaction can be carried out at these temperatures in an inert organicsolvent medium with the ethers such as those mentioned hereinbeforebeing especially suitable for this reaction.

In accordance with this invention the compounds of formula IV areconverted to the known vitamin E intermediates of the formula: ##STR5##where R¹ is as above by conventional procedures. Any conventional methodfor converting a malonic acid to an acetic acid can be utilized in thisconversion. Among the preferred methods is hydrolysis followed bydecarboxylation.

In accordance with this invention the compounds of formula V areconverted to the known vitamin E intermediates of the formula: ##STR6##wherein R¹ is as above; by conventional procedures for converting aterminal double bond to an aldehyde among the preferred methods forcarrying out this reaction is ozonolysis followed by a reductive workup.

In the Examples, reactions described below were carried out under anatmosphere of argon. Column chromatography was performed using EM SilicaGel 60 (0.063-0.2 mm). Anhydrous ether and tetrahydrofuran weredistilled from sodium benzophenone ketyl immediately prior to use. Theether used in these Examples is diethyl ether.

EXAMPLE 1rac-2-Chloro-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran

To a solution of 5 g (16 mmol) ofrac-3,4-dihydro-6-(phenylmethoxy)-2,5,7,8-tetramethyl-2H-1-benzopyran-2-olin 50 mL of anhydrous ether was added 5 g of 4A molecular sieves. Themixture was stirred mechanically with ice-bath cooling while HCl gas wasbubbled in for 30 min. Stirring was continued at 0° C. for 30 min andthen the solvent was removed in vacuo. The residue was treated with 500mL of hexane and the solution was decanted. The hexane solution was thentreated with 10 g of anhydrous CaCl₂ and the mixture stirred for 2 hr.The solids were filtered and the filtrate was concentrated in vacuo to avolume of ca. 20 mL. Crystallization was induced by cooling to -10° C.and stirring, then the remaining solvent was removed in vacuo giving 4.9g (92.8% yield) ofrac-2-chloro-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyranas a colorless solid. The chlorochroman decomposed upon attempted columnor thin layer chromatography. It was stored at 0° C.

EXAMPLE 2rac-2-Chloro-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-olAcetate

A mixture of 10 g (37.9 mmol) ofrac-3,4-dihydro-6-acetyloxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-ol and10 g of 4A molecular sieves in 200 mL of anhydrous ether was stirredwith ice-bath cooling while HCl gas was bubbled in for 30 min. Themixture was filtered and the filtrate concentrated in vacuo. The residuewas taken up in 600 mL of hexane and anhydrous CaCl₂ was added. Themixture was stirred for 1 hr then filtered and the filtrate wasconcentrate in vacuo giving 4.3 g (40.2% yield) ofrac-2-chloro-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-olacetate as a colorless solid, mp 102°-106° C., which was unstable tocolumn or thin layer chromatography.

EXAMPLE 3rac-3,4-Dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran-2-ylpropanedioicAcid Dimethyl Ester

A 370 mg (9.25 mmol) sample of 60% by weight sodium hydride 40% byweight mineral oil dispersion was washed free of oil with hexane andtreated with 20 mL of anhydrous tetrahydrofuran. The resulting slurrywas stirred with ice-bath cooling while 1.056 g (8 mmol) of dimethylmalonate was added dropwise. After stirring for 10 min at 0° C., thesodiomalonate mixture was treated, dropwise, with a solution ofrac-2-chloro-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyranin 4 mL of dry THF. Stirring at 0° C. was continued for 1.5 hr at whichpoint the reaction mixture was poured into water and extracted threetimes with ether. The ether extracts were dried (MgSO₄), filtered, andconcentrated in vacuo giving a yellow, oily residue. This material wasdissolved in 5 mL of pet. ether (30° C.-60° C.) and stirred leading to awhite precipitate. The solid was isolated by filtration andrecrystallized from pet. ether giving 0.4 g (23.4% yield) ofrac-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran-2-ylpropanedioicacid dimethyl ester as a colorless solid, mp 80°-81° C.

EXAMPLE 4rac-3,4-Dihydro-6-(phenylmethoxy)-2-(2-propenyl)-2,5,7,8-tetramethyl-2H-1-benzopyran

To 12 mL (24 mmol) of 2M allylmagnesium chloride in tetrahydrofuran,cooled in an ice bath, was added, with stirring, a solution of 4.95 g(14.98 mmol) ofrac-2-chloro-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyranin 60 mL of anhydrous ether. The reaction mixture was stirred at 0° C.for 6 hr then worked up by being poured into cold, saturated NH₄ Clsolution and ether extraction. The product (5.4 g of a pale-yellow oil)was dissolved in 40 mL of methanol and 10 mL of ether containing 10 mgof p-toluenesulfonic acid monohydrate. The solution was stirred at roomtemperature for 21 hr then concentrated in vacuo. The residue waschromatographed on 75 g of silica gel. Elution with 40:1 parts by volumehexane-ether gave 2.88 g (57.2% yield) ofrac-3,4-dihydro-6-(phenylmethoxy)-2-(2-propenyl)-2,5,7,8-tetramethyl-2H-1-benzopyranas a colorless oil.

EXAMPLE 5 (4R,8R)-1-Bromo-4,8,12-trimethyltridecane

A solution of 10.44 g (45.8 mmol) of(3R,7R)-3,7,11-trimethyldodecan-1-ol in 150 mL of anhydrous pyridine wasstirred in an acetone-ice bath while 17.4 g (91.3 mmol) ofp-toluenesulfonyl chloride was added in one portion. The mixture wasstirred in the acetone-ice bath for 2 hr then kept at 0° C. for 40 hrbefore being quenched by the addition of 300 mL of ice-water. Theproduct was isolated by extraction with 3×300 mL of ether. The etherextracts were combined, washed with 400 mL of cold 3N HCl and saturatedbrine, then dried (MgSO₄), filtered and concentrated in vacuo. There wasobtained 16.6 g (94.9%) of (3R,7R)-3,7,11-trimethyldodecylp-toluenesulfonate.

This tosylate (43.45 mmol) and 4.25 g (86.7 mmol) of sodium cyanide, in80 mL of ethanol and 20 mL of water was stirred and refluxed for 2.5 hr.Most of the ethanol was removed in vacuo and the residue was treatedwith 75 mL of water and 75 mL of saturated brine and extracted with3×100 mL of ether. The ether extracts were combined, washed withsaturated brine, dried (MgSO₄), filtered through a plug of silica gel,and concentrated in vacuo. This afforded 10.25 g (99.5%) of(4R,8R)-4,8,12-trimethyltridecanenitrile as a yellow oil. GC analysisrevealed a purity of 95.2%.

A mixture of this nitrile (43.25 mmol) and 18.4 g (0.33 mol) ofpotassium hydroxide in 162 mL of ethylene glycol and 13.5 mL of waterwas stirred in a 150° C. oil bath for 4 hr then cooled to 0°-5° C. andpoured into 300 mL of 6N HCl. The mixture was extracted with 2×400 mL ofethyl acetate. The organic extracts were combined, washed with 300 mL ofsaturated brine, dried (MgSO₄), filtered and concentrated in vacuogiving 11.1 g (100%) of (4R,8R)-4,8,12-trimethyltridecanoic acid as anoil.

A solution of this acid in 50 mL of toluene was stirred at roomtemperature while 25 mL of sodium bis(2-methoxyethoxy)aluminum hydridein toluene was added dropwise. After being stirred for 3 hr at roomtemperature, the reaction mixture was decomposed by the cautiousaddition of 5 mL of ethanol. The mixture was then treated with 300 mL of6N HCl and extracted with 3×300 mL of ethyl acetate. The organicextracts were combined, washed with 300 mL of saturated brine, dried(MgSO₄), filtered, and concentrated in vacuo. Kugelrohr distillation(160° C. bath temperature, 1 mm Hg) of the residue (9.7 g) gave 7.0 g of(4R,8R)-4,8,12-trimethyltridecanol as a colorless liquid having a GCpurity of 94.5%. The distillation residue contained starting acid andwas re-reduced with 6 mL of sodium bis(2-methoxyethoxy)aluminum hydrideas described above. This provided an additional 1.8 g [total yield 8.8 g(84.2%)] of alcohol having a GC purity of 95.8%.

To a solution of 9.6 g (39.6 mmol) of (4R,8R)-4,8,12-trimethyltridecanolin 30 mL of anhydrous N,N-dimethylformamide was added 10.7 g (40.84mmol) of triphenylphosphine. The solution was stirred in an acetone-icebath (-10° C.) while 2.1 mL (41 mmol) of bromine was added dropwise. Thetemperature rose to 5° C. The reaction mixture was stirred at roomtemperature for 1 hr then poured into 100 mL of water and 150 mL ofhexane. After filtration, the layers were separated and the aqueousphase was extracted with 2×150 mL of hexane. The hexane layers werewashed with saturated NaHCO₃ solution, dried (MgSO₄), filtered through aplug of silica gel, and concentrated in vacuo. Kugelrohr distillation(150°-160° C. bath temperature, 1 mm Hg) of the residue gave 2fractions: 5.15 g of 95.8% GC purity and 3.55 g of 97.9% GC purity(72.2% yield). Redistillation of the larger fraction gave(4R,8R)-1-bromo-4,8,12-trimethyltridecane as a colorless liquid bp 120°C. (0.15 mm) having a GC purity of 97.9%; [a]²⁵ D-3.01° (c 2.09,hexane).

EXAMPLE 6 (2RS,4'R,8'R)-alpha-Tocopheryl Benzyl Ether

A Grignard solution was prepared from 0.28 g (11.2 mmol) of magnesiumand 3.4 g (11.2 mmol) of (4R,8R)-1-bromo-4,8,12-trimethyltridecane in 25mL of anhydrous ether. Grignard formation was induced with a few dropsof 1,2-dibromoethane and the mixture was stirred and refluxed for 3.5hr. To a stirred solution of 2.6 g (7.87 mmol) ofrac-2-chloro-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyranin 25 mL of anhydrous ether, cooled to -10° C. (ice-acetone bath), wasadded the C₁₆ -Grignard solution, dropwise. The resulting mixture wasstirred at 0° C. for 18 hr then treated with 100 mL of saturated NH₄ Clsolution. The product was isolated by extraction with 2×100 mL of ether.The ether extracts were washed with saturated brine, dried (MgSO₄),filtered, and concentrated in vacuo. The residue (4.95 g) was dissolvedin 50 mL of methanol and 30 mL of ether containing 200 mg ofp-toluenesulfonic acid monohydrate. After being stirred at roomtemperature for 24 hr, the solution was concentrated in vacuo and theresidue was chromatographed on 200 g of silica gel. Elution with 40:1parts by volume hexane-ether gave 1.82 g (44.5%) of pure(2RS,4'R,8'R)-alpha-tocopheryl benzyl ether. The identity of thismaterial was proven by spectral and TLC comparison with an authenticsample of (2R,4'R,8'R)-alpha-tocopheryl benzyl ether.

EXAMPLE 7rac-2-chloro-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran

A mixture of 10 g ofrac-2-methoxy-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran,10 g of calcium chloride, 100 ml of hexane and 50 ml of diethyl etherwas stirred at -5° to -10° C. while HCl gas was bubbled in for 1 hr. Anadditional 10 g of calcium chloride was added and stirring was continuedat room temperature for 2 hr. The mixture was filtered and the filtratewas concentrated in vacuo giving 10.2 g of title product as alight-brown oil. Proton NMR analysis revealed that this productconsisted of 66% of the title compound and 33% of the starting 2-methoxychroman.

EXAMPLE 8 A mixture of 0.43 g (1 mmole) ofrac-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran-2-ylpropanedioicacid dimethyl ester, 0.56 g (10 mmoles) of potassium hydroxide, and 25ml of 9:1 ethylene glycol-water is stirred and refluxed for 8 hr. Themixture is cooled, diluted with water, and extracted with ether (theether extract is discarded). The aqueous, alkaline solution is acidifiedwith 3NHCl and the acid product isolated by ether extraction. The etherextracts are combined, washed with water and brine, dried (MgSO₄),filtered and concentrated in vacuo. Recrystallization of the residuefrom aqueous ethanol givesrac-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran-2-aceticacid which can be converted to Vitamin E by the procedures in Helv.Chim. Acta 61, 837 (1978); Helv. Chim. Acta 59, 290 (1976) and Helv.Chim. Acta 64, 1158 (1981). EXAMPLE 9 An ozone-oxygen gas mixture ispassed into a solution of 0.67 g (2 mmoles) ofrac-3,4-dihydro-2,5,7,8-tetramethyl-2-(2-propenyl)-6-(phenylmethoxy)-2H-1-benzopyranin 100 ml of methanol, with stirring, at -78° C. After the startingolefin has been consumed, the ozone flow is stopped and the solution istreated with excess dimethyl sulfide and allowed to warm to roomtemperature. The solution is concentrated in vacuo. The residue ischromatographed on silica gel givingrac-3,4-dihydro-2,5,7,8-tetramethyl-6-(phenylmethoxy)-2H-1-benzopyran-2-acetaldehyde,which can be converted to Vitamin E by the procedures in Helv. Chim.Acta set forth in Example 8. EXAMPLE 10

A 0.6 g (2.13 mmole) sample ofrac-2-chloro-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-olacetate is treated with (4R,8R)-4,8,12-trimethyltridecylmagnesiumbromide as described in Example 6 except that an excess of the Grignardreagent is employed. Chromatography of the crude product on silica gelgives (2RS,4'R,8'R)-alpha-tocopherol as an oil.

EXAMPLE 11

Using the procedure of Example 6,rac-2-chloro-6-methoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyranis treated with (4R,8R)-4,8,12-trimethyltridecylmagnesium bromide togive (2RS,4'R,8'R)-alpha-tocopheryl methyl ether as an oil.

EXAMPLE 12

A solution of 0.25 g (0.56 mmole) of (2RS,4'R,8'R)-alpha-tocopherylmethyl ether in 10 ml of 1,2-dichloroethane is treated with 0.7 g (2.25mmoles) of boron tribromide dimethyl sulfide complex and the reactionmixture is stirred and refluxed for 20 hr. The mixture is cooled andtreated with water. The organic layer is separated, washed with waterand brine, dried (MgSO₄), filtered and concentrated in vacuo. Theresidue is chromatographed on silica gel giving(2RS,4'R,8'R)-alpha-tocopherol as an oil.

EXAMPLE 13

A mixture of 84.3 g (0.337 mole) ofrac.-2,6-dimethoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran, 370ml of acetone, 300 ml of water, and 2.5 ml of conc. hydrochloric acidwas distilled until the distillate temperature reached 90° C. Afterbeing cooled, the mixture was diluted with water and extracted threetimes with ether. The ether extracts were combined, washed withsaturated brine, dried (MgSO₄), filtered, and concentrated in vacuo. Theresidue was recrystallized from aqueous acetone givingrac.-6-methoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-2-ol asan off-white solid, in crops of 34.6 g (43.5%) and 11.1 g (13.9%).

EXAMPLE 14

Using the procedure of Example 1,rac.-6-methoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-2-ol wasconverted intorac.-2-chloro-6-methoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran,an off-white solid, in 90.2% yield.

EXAMPLE 15

Using the procedure of Example 3, except that diethyl malonate wasemployed in place of dimethyl malonate,rac.-2-chloro-6-methoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyranwas converted intorac.-3,4-dihydro-2,5,7,8-tetramethyl-6-methoxy-2H-1-benzopyran-2-ylpropanedioicacid diethyl ester, a colorless solid, m.p. 74°-76° C., in 54% yield,purified by a combination of HPLC and recrystallization from pet. ether.

EXAMPLE 16

A mixture of 1.29 g (3.41 mmoles) ofrac.-3,4-dihydro-2,5,7,8-tetramethyl-6-methoxy-2H-1-benzopyran-2-ylpropanedioicacid diethyl ester, 1.68 g of potassium hydroxide, and 75 ml of 9:1parts by volume ethylene glycol-water mixture was stirred and refluxedfor 6 hours. The resulting mixture was poured on ice and extracted withether (the ether extract was discarded). The aqueous solution wasacidified with 3N HCl and the preciptated acid was extracted 3 timeswith ether. The combined ether extracts were washed with brine, dried(MgSO₄), filtered and concentrated in vacuo. Purification of the residueby preparative thick layer chromatography gave 0.72 g (75.9%) ofrac.-3,4-dihydro-6-methoxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-aceticacid, as a colorless solid, mp 96°-98° C. Demethylation using theprocedure of example 14 givesrac.-3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-aceticacid which can be converted to alpha-tocopherol as described in Helv.Chim. Acta. 59, 290 (1976).

EXAMPLE 17

A mixture of 200 g (0.847 mole) ofrac.-3,4-dihydro-2-methoxy-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol,1200 ml of acetone, 200 ml of dimethyl sulfate, and 100 g of sodiumhydroxide in 100 ml of water was stirred at room temperature for 4 hourswhereupon 500 ml of 10% aqueous ammonium hydroxide solution was addedand stirring continued for 30 minutes. The mixture was extracted 3 timeswith ether. The ether extracts were combined, washed with water andsaturated brine, dried (MgSO₄), filtered and concentrated in vacuogiving 238.4 g of residue which was recrystallized from ether-hexane at-20° C. There was obtained 145.9 g (68.9%) ofrac.-2,6-dimethoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran as acolorless solid. The product upon being recrystallized from hexane at-60° C., gave a solid, mp 37°-38° C.

Anal. Calcd. for C₁₅ H₂₂ O₃ : C, 71.97; H, 8.86. Found: C, 71.84; H,8.82.

I claim:
 1. A compound of the formula: ##STR7## wherein R¹ is methyl ora hydroxy protecting group removable by basic hydrolysis orhydrogenolysis.
 2. The compound of claim 1 wherein R¹ is aralkyl orlower alkanoyl.
 3. The compound of claim 2 wherein said compound is3,4-dihydro-6-(phenylmethoxy)-2-(2-propenyl)-2,5,7,8-tetramethyl-2H-1-benzopyran.